CRDF Message Board Post 10896100 | Cardiff Oncology Inc.
home / stock / crdf / crdf message board
superman
(investorshangout)
Posted on: Apr/18/2015 04:59:04
Source: investorshangout
https://investorshangout.com/post/view?id=2880271
Jake13: TROV Stock year to date has changed +98.37% percent. +18.80% in the last 30 days. $TROV Trovagene
News, Short Squeeze, Breakout and More Instantly...
-
SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will present at two upcoming investor conferences in M...
-
- In RAS-mutated mCRC, clinical data from ONSEMBLE trial, and preclinical data presented at AACR, demonstrated strong efficacy signal in bev naïve patients and support ongoing first-line RAS-mutated mCRC lead program - - In RAS wild-type mCRC, preclinical data presented at AACR dem...